Bi Asset Management Fondsmaeglerselskab A Alnylam Pharmaceuticals, Inc. Transaction History
Bi Asset Management Fondsmaeglerselskab A
- $6.11 Billion
- Q2 2024
A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 4,562 shares of ALNY stock, worth $1.23 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,562
Previous 3,724
22.5%
Holding current value
$1.23 Million
Previous $557,000
99.1%
% of portfolio
0.02%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ALNY
# of Institutions
639Shares Held
109MCall Options Held
2.33MPut Options Held
2.15M-
Capital World Investors Los Angeles, CA15MShares$4.04 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.38 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.58 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.68 Billion0.28% of portfolio
-
Baillie Gifford & CO4.89MShares$1.32 Billion1.03% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.2B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...